- Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7Xie, Chen; Chen, Yanlian; Luo, Dongling; Zhuang, Zhen; Jin, Heping; Zhou, Haoxian; Li, Xiaocui; Lin, Haijun; Zheng, Xiaohui; Zhang, Jing; Wang, Peihui; Zhao, Jincun; Zhao, Yong*; Huang, Hui*Signal Transduction and Targeted Therapy, 2021, 6(1): 84.被引 18
- Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulationHua, Chen; Ma, Qinhai; Zhu, Yun; Xia, Shuai; Liu, Zezhong; Li, Lin; Lu, Lu; Zhong, Nanshan; Liu, Shuwen*; Yang, Zifeng*; Jiang, Shibo*Signal Transduction and Targeted Therapy, 2021, 6(1): 318.被引 7
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseasePeter Richardson; Ivan Griffin; Catherine Tucker; Dan Smith; Olly Oechsle; Anne Phelan; Justin StebbingLancet, 2020, 395(10223): e30-e31.
期刊论文
Antiviral Efficacy of Pralatrexate against SARS-CoV-2
17阅读
